This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción HR6
Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Healthcare Realty Trust Incorporated
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$23.40 |
| 52 Week High | US$29.00 |
| 52 Week Low | US$23.00 |
| Beta | 0.60 |
| 1 Month Change | -5.65% |
| 3 Month Change | -7.87% |
| 1 Year Change | -12.69% |
| 3 Year Change | -17.55% |
| 5 Year Change | -16.18% |
| Change since IPO | -12.91% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| HR6 | DE REITs | Mercado DE | |
|---|---|---|---|
| 7D | -3.3% | -0.8% | -2.0% |
| 1Y | -12.7% | -3.3% | -0.3% |
Rentabilidad vs. Industria: HR6 exceeded the German REITs industry which returned -23.9% over the past year.
Rentabilidad vs. Mercado: HR6 exceeded the German Market which returned -21.9% over the past year.
Volatilidad de los precios
| HR6 volatility | |
|---|---|
| HR6 Average Weekly Movement | 5.1% |
| REITs Industry Average Movement | 2.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: HR6 has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: HR6's weekly volatility (5%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1992 | 338 | Todd Meredith | www.healthcarerealty.com |
Resumen de fundamentos de Healthcare Realty Trust Incorporated
| Estadísticas fundamentales de HR6 | |
|---|---|
| Capitalización bursátil | €3.60b |
| Beneficios(TTM) | €80.84m |
| Ingresos (TTM) | €534.01m |
44.7x
Ratio precio-beneficio (PE)6.8x
Ratio precio-ventas (PS)¿Está HR6 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de HR6 | |
|---|---|
| Ingresos | US$545.91m |
| Coste de los ingresos | US$222.01m |
| Beneficio bruto | US$323.90m |
| Otros gastos | US$241.25m |
| Beneficios | US$82.65m |
Últimos beneficios comunicados
Mar 31, 2022
Próxima fecha de beneficios
Aug 09, 2022
| Beneficios por acción (BPA) | 0.55 |
| Margen bruto | 59.33% |
| Margen de beneficio neto | 15.14% |
| Ratio deuda/patrimonio | 86.2% |
¿Cómo se ha desempeñado HR6 a largo plazo?
Ver rendimiento histórico y comparativa